Sale Of Common Stock, Maximum Proceeds From Agreement

No definition available.

Name:	sppi_SaleOfCommonStockMaximumProceedsFromAgreement
Namespace Prefix:	sppi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sppi_April2019ATMAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sppi_RegistrationStatementJuly2021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=sppi_SecuritiesPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=sppi_HanmiPharmaceuticalCoLtdHanmiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Stockholders' Equity - Narrative (Details) - USD ($)					1 Months Ended	9 Months Ended
Stockholders' Equity - Narrative (Details) - USD ($)	Jul. 21, 2021	Nov. 06, 2020	May 08, 2020	Apr. 05, 2019	Jan. 31, 2022	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from sale of common stock under an at-the-market sales agreement, net						$ 26,560,000	$ 52,622,000
April 2019 ATM Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum proceeds		$ 60,000,000	$ 75,000,000	$ 150,000,000
Registration Statement, July 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum proceeds	$ 300,000,000
Registration Statement, July 2021 \| Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum proceeds	$ 150,000,000
Securities Purchase Agreement \| Hanmi Pharmaceutical Co. Ltd. (“Hanmi”)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares sold in public offering (in shares)					12,500,000
Shares sold in public offering (in dollars per share)					$ 1.60
Proceeds from sale of common stock under an at-the-market sales agreement, net					$ 20,000,000